# Evaluation of Salivary Adseverin, 1-Alpha Defensin and sRANKL Levels of Individuals With Different Periodontal Diseases

> **NCT06402877** · NA · COMPLETED · sponsor: **Izmir Katip Celebi University** · enrollment: 60 (actual)

## Conditions studied

- Periodontal Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Saliva obtaining

## Key facts

- **NCT ID:** NCT06402877
- **Lead sponsor:** Izmir Katip Celebi University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-26
- **Primary completion:** 2025-02-25
- **Final completion:** 2025-11-24
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06402877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06402877, "Evaluation of Salivary Adseverin, 1-Alpha Defensin and sRANKL Levels of Individuals With Different Periodontal Diseases". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06402877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*